Blood extractions, transfusion policy and erythropoietin in the newborn;Extracciones sanguineas, politica transfusional y eritropoyetina en el prematuro

Anales Espanoles de Pediatria

Volumn 49, Issue 1, 1998, Pages 46-48

  Figueras Aloy, J ^a   Carbonell Estrany, X ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IRON DEXTRAN; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; ERYTHROPOIETIN;

ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CLINICAL PROTOCOL; COST BENEFIT ANALYSIS; HEALTH CARE POLICY; HEMATOCRIT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY ANEMIA; NEWBORN; NEWBORN ANEMIA; ORAL DRUG ADMINISTRATION; PREMATURITY; UMBILICAL CORD BLOOD; ANEMIA; BLOOD; ERYTHROCYTE TRANSFUSION; METHODOLOGY; PRACTICE GUIDELINE; REVIEW; SPAIN;

ANEMIA; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN; GUIDELINES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; SPAIN;

EID: 0032111221     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ringer SA, Richardson DK, Sachcr RA, Keszler M, Hallowell W. Variations in transfusion practice in neonatal intensive care unit. Pediatrics 1998; 101:194-200.
2. Shannon KM, Mentzer WC, Abels RI, Freeman P, Newton N y cols. Recombinant human erythropoietin in the anemia of prematurity: Results of a placebo-controlled pilot study. J Pediatr 1991; 118:949-955.
3. Ohls RK, Harcum J, Schibler KR, Christensen RD. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: A randomized, double-blind, placebo controlled study. J Pediatr 1997; 131:661-665.
4. Obladen M, Sachsenweger M, Stahnke M. Blood sampling in very low birth weight infants receiving different levels of intensive care. Eur J Pediatr 1988; 147:399-404.
5. Lachance C, Cheessex P, Fouron JC, Widness JA, Bard H. Myocardial, erythropoietic, and metabolic adaptations to anemia of prematurity. J Pediatr 1994; 125:278-282.
6. Al-Kharfy T, Smyth JA, Wadsworth L, Krystal G, Fitzgerald C, Davis J, Milner R. Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions. J Pediatr 1996; 129:89-96.
7. Bifano EM, Curran TR. Minimizing donor blood exposure in the neonatal intensive care unit: current trends and future prospects. Clin Perinatol 1995; 22:657-670.
8. Rodríguez-Miguélez JM. Transfusiones en el recién nacido. Arch Pediatr 1993; 44:90-94.
9. Anderson S, Fangman J, Wager G, Uden D. Retrieval of placental blood from the umbilical vein to determine volume, sterility and presence of clot formation. Am J Dis Child 1992; 146:36-39.
10. Strauss RG. Autologous Transfusions for Neonates Using Placental Blood. A Cautionary Note. Am J Dis Child 1992; 146:21-22.
11. Perapoch J, Castilla J, Llopart T, Castellaá D, Salcedo S. Reducción de la exposición a múltiples donantes en recién nacidos pretérmino de peso inferior a 1.500 g. An Esp Pediatr 1997; 47:551-552.
12. Shannon KM, Keith JF, Mentzer WC, Ehrenkranz RA, Brown MS, Widness JA, Gleason CA, Bifano EM y cols. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocite transfusions in very low birth weight preterm infants. Pediatrics 1995; 95:1-8.
13. Strauss RG. Red blood cell transfusion practices in the neonate. Clin Perinatol 1995; 22:641-656.
14. Strauss RG. Recombinant erythropoietin for the anemia of prematurity: still a promise, not a panacea. J Pediatr 1997; 131:653-655.
15. Ohls RK, Liechty KW, Turner MC, Kimura RE, Christensen RD. Erythroid «Burst Promoting» activity in serum of patients with de Anemia of Prematurity. J Pediatr 1990; 116:786-789.
16. Messer J, Haddad J, Donato L, Astruc D, Matis J. Early treatment of premature infants with recombinant human erythropoietin. Pediatrics 1993; 92:519-524.
17. Halperin DS, Wacker P, Lacourt G, Felix M, Babel JF, Aapro M, Wyss M. Effects of recombinant human erythropoietin in infants with the anemia of prematurity: A pilot study. J Pediatr 1990; 116:779-786.
18. Emmerson AJB, Coles HJ, Stern CMM, Pearson TC. Double blind trial of recombinant human erythropoietin in preterm infants. Arch Dis Child 1993; 68:291-296.
19. Soubasi V, Kremenopoulos G, Diamandi E, Tsantali C, Tsakiris D. In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study. Pediatr Res 1993; 34:675-679.
20. Bard H, Widness JA. Effect of recombinant human erythropoietin on the switchover from fetal to adult hemoglobin synthesis in preterm infants. J Pediatr 1995; 127:478-480.
21. Widness JA, Lombard KA, Ziegler EE, Serfass RE, Carlson SJ, Johnson KJ, Miller JE. Erythrocyte incorporation and absorption of 58-Fe in premature infants treated with erythropoietin. Pediatr Res 1997; 41:416-423.
22. Ohls RK, Christensen RD. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity. J Pediair 1991; 119:781-788.
23. Gallagher PG, Ehrenkranz RA. Erythropoietin therapy for anemia of prematurity. Clin Perinatol 1993; 20:169-191.
24. Shannon K. Recombinant human erythropoietin in neonatal anemia. Clin Perinatol 1995; 22:627-640.
25. Soubasi V, Kremenopoulos G, Diamanti E, Tsantali C, Sarafidis K, Tsakiris D. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity. J Pediatr 1995; 127:291-297.
26. Javier Manchon G, Natal A, Coroleu W, Zuasnabar A, Badía J, Junca J, Bel J, Sabado C, Prats J. Estudio multicéntrico aleatorizado de administración de eritropoyetina en la anemia de la prematuridad. An Esp Pediatr 1997; 46:587-592.
27. Griffiths G, Lall R, Chatfield S, Short A, Mackay P, Williamson P, Brown J, Levene MI. Randomised controlled double blind study of role of recombinant erythropoietin in the prevention of chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1997; 76(F): 190-192.
28. Meyer M, Meyer J, Commeford A y cols. Recombinant human erythropoietin in the treatment of anemia of prematurity: results of a double blind, placebo-controlled study. Pediatrics 1994; 93:918-924.
29. Maier RF for the European Multicentre Erythropoietin Study. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. N Engl J Med 1994; 330:1173-1178.
30. Ohls RK, Osborne KA, Christensen RD. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: A randomized, placebo-controlled trial. J Pediatr 1995; 126:421-426.
31. Caplan M, Millard D. Efficacy and cost analysis of treating low birth weight infants with erythropoietin. J Pediatr 1995; 127:672-673.
32. Asch J, Wedgwood JF. Optimizing the approach to anemia in the preterm infant: is there a role for erythropoietin therapy? J Perinatol 1997; 17:276-282.
33. Ohls RK, Veerman MW, Chnstensen RD. Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continous infusion in total parenteral nutrition. J Pediatr 1996; 128:518-523.
34. Meyer MP, Haworth C, Meyer JH, Commerford A. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin. J Pediatr 1996; 129:258-263.
35. Bechensteen AG, Haga P, Halvorsen S, Liestol K, Lindermann R, Whitelaw A, Tollosfrud PA, Daae L y cols. Effect of low and moderate doses of recombinant human erythropoietin on the hematological response in premature infants on a high protein and iron intake. Eur J Pediatr 1997; 156:56-61.
36. Brown MS, Shapiro H. Effect of protein intake on erythropoiesis during erythropoietin treatment of anemia of prematurity. J Pediatr 1996; 128:512-517.
37. Wilimas JA, Crist WM. Erythropoietin - not yet a standard treatment for anemia of prematurity. Pediatrics 1995; 95:9-10.